Tazveric tablets 200mg, from Eisai, contains Tazemetostat hydrobromide (YJ code: 4291073F1029, standard: 200mg x 1 tablet). This medication is a selective inhibitor of the EZH2 enzyme, which plays a critical role in gene regulation. It is indicated for the treatment of epithelioid sarcoma and follicular lymphoma by restoring normal gene expression patterns.
Tazveric tablets 200mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
